Evolution of Facial Trauma During COVID Containment Measures

NCT04355442 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-07-29

No results posted yet for this study

Summary

The COVID-19 global pandemic has led to a major professional and social national reorganization: professional because it involves a redeployment of medical staff and material resources, and social because it imposes prolonged containment measures on an entire population.

The maxillofacial trauma activity is mainly linked to sports or leisure accidents, fights and road accidents.

It seems to appear since the beginning of containment measures a significant drop in maxillofacial trauma activity at the national level, which, if it is demonstrated in a significant way in several French hospital centers, would allow to redeploy the material and human resources related to this activity on sectors in tension due to the pandemic.

Conditions

  • Maxillofacial Injuries
  • Skull Fractures
  • COVID-19

Interventions

PROCEDURE

Facial fractures reduction or osteosynthesis

Facial fractures reduction or osteosynthesis

Sponsors & Collaborators

  • Unités de CMF des CHU de Paris (Dr Davrou - Pitié salpetrière)

    collaborator UNKNOWN
  • Amiens (Dr Dapke)

    collaborator UNKNOWN
  • Nantes (Pr Corre)

    collaborator UNKNOWN
  • Toulouse (Pr Lauwers - Purpan)

    collaborator UNKNOWN
  • Marseille (Dr Foletti - La conception)

    collaborator UNKNOWN
  • Nice (Dr Savoldelli)

    collaborator UNKNOWN
  • Clermont Ferrand (Dr Sesque)

    collaborator UNKNOWN
  • Perpignan (Dr Llobet)

    collaborator UNKNOWN
  • Lyon (Dr Bourlet - Croix Rousse)

    collaborator UNKNOWN
  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Marie de BOUTRAY, PH · UH MONTPELLIER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-05-01
Completion
2020-05-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04355442 on ClinicalTrials.gov